• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于脑钠肽的策略检测恰加斯病左心室功能障碍:与传统方法的比较

Brain natriuretic peptide based strategy to detect left ventricular dysfunction in Chagas disease: a comparison with the conventional approach.

作者信息

Ribeiro Antonio Luiz P, Teixeira Mauro M, Reis Adelina M, Talvani Andre, Perez Amanda A, Barros Márcio Vinicius L, Rocha Manoel Otávio C

机构信息

Postgraduate Course of Tropical Medicine, Internal Medicine Department, School of Medicine, Federal University of Minas Gerais, Av. Alfredo Balena, 190-Campus Saúde, 30130-100, Belo Horizonte, Brazil.

出版信息

Int J Cardiol. 2006 Apr 28;109(1):34-40. doi: 10.1016/j.ijcard.2005.05.048. Epub 2005 Jul 14.

DOI:10.1016/j.ijcard.2005.05.048
PMID:16023747
Abstract

BACKGROUND

Left ventricular dysfunction (LVd) is the main predictor of mortality in Chagas disease (ChD).

AIMS

To compare the diagnostic performance of the conventional approach (ECG and chest X-ray) in the recognition of LVd in ChD, with a new strategy, in which BNP is measured in patients with an abnormal ECG.

METHODS

Consecutive ChD patients recruited at an Outpatient Reference Center in Belo Horizonte, Brazil, without other systemic diseases, in 1998-99 (sample 1, n = 165) and in 2001-02 (sample 2, n = 62) underwent ECG, chest X-ray, BNP measurement and echocardiography.

RESULTS

The prevalence of LVd (ejection fraction <or=0.40) was 9.1% in the sample 1. The conventional strategy recognized all patients with LVd (sensitivity: 100%, 95% CI: 79.6-100% and negative predictive value -PV 100%, 92.1-100%), but with low specificity (30%, 95% CI: 23.2-37.8) and +PV (12.5%, 95% IC: I7.7-19.6). The BNP/ECG strategy showed significantly better specificity (96.0%, 95% CI: 91.5-98.2, p < 0.001) and +PV (66.7%, 95% CI: 43.7-83.7, p < 0.001), and non-significantly lower sensitivity (80.0%, 95% CI: 54.8-93.0, p = 0.25) and -PV (98.0%,95% CI: 94.2-99.3, p = 0.08). Overall accuracy was improved with the new strategy. (94.5%,95% CI: 90.0-97.1 x 36.4%, 95% CI: 29.4-43.9, p < 0.001). Similar results were obtained for the sample 2.

CONCLUSIONS

The BNP-based strategy was more accurate than the conventional approach in the detection of LVd in ChD patients and should be considered as a valid option.

摘要

背景

左心室功能障碍(LVd)是恰加斯病(ChD)死亡率的主要预测指标。

目的

比较传统方法(心电图和胸部X线)与一种新策略在识别ChD患者LVd方面的诊断性能,新策略是对心电图异常的患者测量脑钠肽(BNP)。

方法

1998 - 1999年(样本1,n = 165)和2001 - 2002年(样本2,n = 62)在巴西贝洛奥里藏特的一家门诊参考中心招募的连续ChD患者,无其他系统性疾病,接受了心电图、胸部X线、BNP测量和超声心动图检查。

结果

样本1中LVd(射血分数≤0.40)的患病率为9.1%。传统策略识别出了所有LVd患者(敏感性:100%,95%可信区间:79.6 - 100%;阴性预测值 -PV 100%,92.1 - 100%),但特异性较低(30%,95%可信区间:23.2 - 37.8)和阳性预测值(+PV)较低(12.5%,95%可信区间:7.7 - 19.6)。BNP/心电图策略显示出显著更高的特异性(96.0%,95%可信区间:91.5 - 98.2,p < 0.001)和 +PV(66.7%,95%可信区间:43.7 - 83.7,p < 0.001),而敏感性(80.0%,95%可信区间:54.8 - 93.0,p = 0.25)和 -PV(98.0%,95%可信区间:94.2 - 99.3,p = 0.08)无显著降低。新策略提高了总体准确性(94.5%,95%可信区间:90.0 - 97.1对36.4%,95%可信区间:29.4 - 43.9,p < 0.001)。样本2也得到了类似结果。

结论

基于BNP的策略在检测ChD患者的LVd方面比传统方法更准确,应被视为一种有效的选择。

相似文献

1
Brain natriuretic peptide based strategy to detect left ventricular dysfunction in Chagas disease: a comparison with the conventional approach.基于脑钠肽的策略检测恰加斯病左心室功能障碍:与传统方法的比较
Int J Cardiol. 2006 Apr 28;109(1):34-40. doi: 10.1016/j.ijcard.2005.05.048. Epub 2005 Jul 14.
2
[Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].[高危患者无症状性左心室收缩功能障碍的筛查。基于心电图和利钠肽检测的项目初步经验]
G Ital Cardiol (Rome). 2008 Dec;9(12):835-43.
3
Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.N端前B型利钠肽与B型利钠肽在有/无左心室收缩功能障碍患者中的头对头比较。
Clin Biochem. 2006 Jun;39(6):640-5. doi: 10.1016/j.clinbiochem.2006.01.021. Epub 2006 Mar 3.
4
Neurohormonal activation and diagnostic value of cardiac peptides in patients with suspected mild heart failure.
Int J Cardiol. 2006 Jun 28;110(3):324-33. doi: 10.1016/j.ijcard.2005.08.003. Epub 2005 Oct 6.
5
Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.N末端B型利钠肽原(NT-proBNP)对慢性肾脏病5期血液透析患者左心室功能障碍的诊断价值
Nephrol Dial Transplant. 2008 Apr;23(4):1370-7. doi: 10.1093/ndt/gfm700. Epub 2007 Dec 18.
6
Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.慢性心力衰竭中利钠素原中段和B型利钠肽的比较:影响因素、左心室收缩功能障碍的检测及死亡预测
J Am Coll Cardiol. 2009 May 12;53(19):1783-90. doi: 10.1016/j.jacc.2009.01.057.
7
Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.N末端前脑钠肽在识别高危无症状患者左心室功能障碍中的准确性。
J Cardiovasc Med (Hagerstown). 2009 Mar;10(3):238-44. doi: 10.2459/JCM.0b013e3283212ee0.
8
N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.N末端前体脑钠肽作为检测低心功能分级患者和心脏移植候选者的标志物:与运动耐量的线性相关性。
J Heart Lung Transplant. 2007 May;26(5):516-21. doi: 10.1016/j.healun.2007.01.026. Epub 2007 Mar 21.
9
Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.连续床边检测B型利钠肽能独立于超声心动图异常情况,有力地预测急性冠状动脉综合征的预后。
Am Heart J. 2009 Jul;158(1):133-40. doi: 10.1016/j.ahj.2009.04.024.
10
Diagnostic accuracy of plasma brain natriuretic peptide and aminoterminal-proBNP in mild heart failure depends on assay and introduction of therapy.血浆脑钠肽和氨基末端脑钠肽前体在轻度心力衰竭中的诊断准确性取决于检测方法和治疗的引入。
Scand J Clin Lab Invest. 2005;65(8):633-47. doi: 10.1080/00365510500333577.

引用本文的文献

1
Circulating microRNAs as biomarkers of Chagas cardiomyopathy.循环微RNA作为恰加斯心肌病的生物标志物
Front Cardiovasc Med. 2023 Dec 19;10:1250029. doi: 10.3389/fcvm.2023.1250029. eCollection 2023.
2
Prognosis of chronic Chagas heart disease and other pending clinical challenges.慢性恰加斯心脏病的预后及其他待解决的临床挑战。
Mem Inst Oswaldo Cruz. 2022 Jun 6;117:e210172. doi: 10.1590/0074-02760210172. eCollection 2022.
3
Left ventricular systolic dysfunction predicted by artificial intelligence using the electrocardiogram in Chagas disease patients-The SaMi-Trop cohort.
人工智能利用心电图预测恰加斯病患者的左心室收缩功能障碍——SaMi-Trop 队列研究。
PLoS Negl Trop Dis. 2021 Dec 6;15(12):e0009974. doi: 10.1371/journal.pntd.0009974. eCollection 2021 Dec.
4
Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease.炎症和心脏生物标志物在恰加斯病的临床阶段存在差异表达。
Int J Cardiol. 2015 Nov 15;199:451-9. doi: 10.1016/j.ijcard.2015.07.040. Epub 2015 Jul 12.
5
Biomarkers in Trypanosoma cruzi-infected and uninfected individuals with varying severity of cardiomyopathy in Santa Cruz, Bolivia.玻利维亚圣克鲁斯患有不同严重程度心肌病的克氏锥虫感染和未感染个体中的生物标志物
PLoS Negl Trop Dis. 2014 Oct 2;8(10):e3227. doi: 10.1371/journal.pntd.0003227. eCollection 2014 Oct.
6
Electrocardiographic abnormalities in elderly Chagas disease patients: 10-year follow-up of the Bambui Cohort Study of Aging.老年恰加斯病患者的心电图异常:班比老龄化队列研究的 10 年随访。
J Am Heart Assoc. 2014 Feb 7;3(1):e000632. doi: 10.1161/JAHA.113.000632.
7
Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors.克氏锥虫血清阳性和血清阴性前献血者的心电图异常。
PLoS Negl Trop Dis. 2013;7(2):e2078. doi: 10.1371/journal.pntd.0002078. Epub 2013 Feb 28.
8
Diagnosis and management of Chagas disease and cardiomyopathy.**诊断和治疗**:恰加斯病和心肌病。
Nat Rev Cardiol. 2012 Oct;9(10):576-89. doi: 10.1038/nrcardio.2012.109. Epub 2012 Jul 31.
9
Chagas heart disease: report on recent developments.恰加斯心脏病:近期进展报告。
Cardiol Rev. 2012 Mar-Apr;20(2):53-65. doi: 10.1097/CRD.0b013e31823efde2.
10
Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.慢性恰加斯心脏病:一种即将成为全球性健康问题的疾病:流行病学、病因病理学、治疗、发病机制和实验室医学。
Heart Fail Rev. 2012 Jan;17(1):45-64. doi: 10.1007/s10741-010-9211-5.